Applied Policy Insight is Applied Policy’s monthly newsletter, published in the interest of sharing both our insights into healthcare policy and a little more about ourselves, as a team and as individuals.
READ THE DECEMBER 2024 ISSUE OF APPLIED POLICY INSIGHT
In the December 2024 edition of Applied Policy Insight, Applied Policy President and CEO Jim Scott reflects upon how the company’s commitment to saving lives has driven a record of success for clients. Senior Health Policy Associates Emma Hammer and Caitlyn Bernard share insights from their analysis of the Part B drugs subject to inflation rebates for 2024, and we revisit our 2024 stories with an eye toward changes under the second Trump administration.
READ THE NOVEMBER 2024 ISSUE OF APPLIED POLICY INSIGHT
In the November 2024 edition of Applied Policy Insight, Applied Policy President and CEO Jim Scott looks towards possible changes in health policy under a new presidential administration in 2025 and Health Policy Vice President Alison Falb discusses the potential implications of a forthcoming rule from HHS, the Departments of Labor and Treasury on copay accumulators and maximizers. You can also find Health Policy Associate Caitlyn Bernard’s article on the future of CMS’s Best Price ‘Stacking’ proposal. And, the team has reports from AMCP Nexus and NCQA’s Innovation Summit.
READ THE OCTOBER 2024 ISSUE OF APPLIED POLICY INSIGHT
In the October 2024 edition of Applied Policy Insight, Applied Policy President and CEO Jim Scott shares his thoughts on shaping the future of drug price negotiations and Health Policy Associate Emma Hammer discusses the possibility of MAC consolidations. You can also find a summary of CMS’s education session on the Transitional Coverage for Emerging Technologies (TCET) pathway and the latest on another delay of PAMA implementation.
READ THE SEPTEMBER 2024 ISSUE OF APPLIED POLICY INSIGHT
In the September 2024 edition of Applied Policy Insight, we consider compounding pharmacies and the anniversary of the two-midnight rule. We also congratulate Alison Falb on her appointment as Vice President for Health Policy.
READ THE AUGUST 2024 ISSUE OF APPLIED POLICY INSIGHT
In the August 2024 edition of Applied Policy Insight, we examine the response of non-diabetes advocacy groups to MEDCAC’s consideration of diabetes devices, take a look at states’ responses to healthcare issues, and offer a primer on patent thickets.
READ THE JULY 2024 ISSUE OF APPLIED POLICY INSIGHT
In the July 2024 edition of Applied Policy Insight, we discuss the impact of recent Supreme Court decisions on healthcare policy and announce the launch of the Applied Policy podcast.
READ THE JUNE 2024 ISSUE OF APPLIED POLICY INSIGHT
In the June 2024 edition of Applied Policy Insight, we look at the transformation of Medicare Part D with an examination of the new out-of-pocket cap and Medicare prescription payment and consider the challenges of realizing heat equity in extreme heat.
READ THE MAY 2024 ISSUE OF APPLIED POLICY INSIGHT
In the May 2024 edition of Applied Policy Insight, we examine the FDA’s final rule on LDTs, look into what insights the TEAM model may hold to understanding the implementation of value-based care, and recognize an opportunity to advise CMS on addressing prior authorization issues in the Medicare Advantage Program.
READ THE APRIL 2024 ISSUE OF APPLIED POLICY INSIGHT
In the April 2024 edition of Applied Policy Insight, learn about the Medicare and Medicaid Disproportionate Share Hospital programs, read about our visit to MedTrade, and read the inaugural edition of our new column on artificial intelligence.
READ THE MARCH 2024 ISSUE OF APPLIED POLICY INSIGHT
In the March 2024 edition of Applied Policy Insight, find a primer on CMS’s competitive bidding and read about the history of the Scribner shunt.
READ THE FEBRUARY 2024 ISSUE OF APPLIED POLICY INSIGHT
In the February 2024 edition of Applied Policy Insight, FDA & CMS indicate alignment on regulatory approach to LDTs and the federal government’s strategies to protect American healthcare from cyberattacks.
READ THE JANUARY 2024 ISSUE OF APPLIED POLICY INSIGHT
In the January 2024 edition of Applied Policy Insight, find a primer on HCPCS and read about the continuing threat of ransomware in healthcare.
READ THE DECEMBER 2023 ISSUE OF APPLIED POLICY INSIGHT
In the December 2023 edition of Applied Policy Insight, we examine physician licensing, credentialing, and privileging and look back at the year in healthcare policy.
READ THE NOVEMBER 2023 ISSUE OF APPLIED POLICY INSIGHT
In the November 2023 edition of Applied Policy Insight, Meghan Basler explains Current Procedural Terminology (CPT®) in the second installment of her series on medical coding, Emma Hammer examines the implications of underrepresenting Native Americans in medical research, and we offer summaries of the latest rules from CMS.
READ THE OCTOBER 2023 ISSUE OF APPLIED POLICY INSIGHT
In the October 2023 edition of Applied Policy Insight, Meghan Basler explains the ICD-10-CM as the first installment of her series on medical coding, Stephanie Lomas updates readers on CMS’s implementation of the discarded drug refund program, and we share our latest summaries of pertinent regulations.
READ THE SEPTEMBER 2023 ISSUE OF APPLIED POLICY INSIGHT
In the September 2023 edition of Applied Policy Insight, we considered the current challenges in risk adjustment, reviewed the use of artificial intelligence at the Department of Health and Human Services, and shared our summaries of CMS rules.
NEWSLETTER ARCHIVE
July/August 2023: Administrative Law Judges in the Office of Medicare Hearings and Appeals, Prior authorizations and health equity
June 2023: Prior authorizations in Medicare Advantage, step therapy, health equity on Juneteenth, new team members
May 2023: Prior authorizations and the U.S. healthcare system, Unified Program Integrity Contractors, COVID reflections, and our new COO
April 2023: The debate over prior authorizations, the growing conversation over food as medicine, Applied Policy’s latest summaries
March 2023: When medicine gets it wrong, expanded coverage for continuous glucose monitors, CMS eliminates CMNs and DIFs
February 2023: The implications of a new Alzheimer’s drug, focus on Europe, 13 years of Recovery Audit Contractors
January 2023: Understanding CMS’s discarded drugs policy, the roots and implications of the United States’ pharmacy shortage, reconciling health equity and value based payments
December 2022: Sexual equality in clinical tests, a look at managed care organizations, and looking towards the end of the public health emergency